Scientists report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.
Click here for original story, Targeting a human protein to squash SARS-CoV-2 and other viruses
Source: ScienceDaily